-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下：SGI第一季營收為18.02億美元，低於預期，這是自2025年第一季以來連續第四季度營收未達預期。儘管營收低於預期，但調整後每股收益為0.59美元，高於預期，這主要得益於各業務板塊業績的差異。 Tempur Sealy北美業務部門的營業利潤率顯著提升710個基點至24.3%，而Mattress Firm則因促銷支出而面臨巨大壓力，毛利率下降360個基點至4.9%。管理層重申了2026年全年調整後每股收益預期為3.00美元至3.40美元，顯示公司對透過持續實現協同效應來達成年度目標充滿信心。收購Leggett & Platt的最終協議旨在深化垂直整合並釋放更多價值，但同時也帶來了Mattress Firm整合完成過程中的執行風險。我們預期床上用品市場將持續波動，潛在的消費趨勢表明，消費者在促銷活動期間主要表現出注重性價比的行為。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO